SCHEMBL19794480

SCHEMBL19794480

CC1(C)c2ccccc2-c2cc(-c3nc(Cl)nc(-c4ccc5c(c4)-c4ccccc4C5(C)C)n3)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 7/20 0.35
MEN1 O00255 6/20 0.34
KMT2A Q03164 6/20 0.34
L3MBTL1 Q9Y468 4/20 0.34
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
PGR P06401 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23079792 0.97 PDK2 (0.35) PDK2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL21870998 0.96 MEN1 (0.40) PDK2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL30934022 0.96 MEN1 (0.40) PDK2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL21709122 0.94 MEN1 (0.39) PDK2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL25845223 0.92 ALDH1A1 (0.35) PDK2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL31027160 0.91 PDK2 (0.38) PDK2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL15274143 0.91 PDK2 (0.38) PDK2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL22914302 0.89 PDK2 (0.39) PDK2MEN1KMT2AALDH1A1PGR
SCHEMBL16383440 0.88 PDK2 (0.38) PDK2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL31517060 0.88 PDK2 (0.38) PDK2MEN1KMT2AL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220069233-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO.,LTD. (KR) 2022-03-03 US disclosed
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC PDK2 3655/4885MEN1 2821/4885KMT2A 3131/4885
US-20220069233-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OR10J3, OR51E2, AOX1 PDK2 1286/4885MEN1 4342/4885KMT2A 3143/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 PDK2 2111/4885MEN1 1212/4885KMT2A 3024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.